ALT LAWSUIT ALERT: The Gross Law Firm Notifies Altimmune, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineGlobeNewsWire • 06/18/24
Altimmune Announces Oral Presentations of Pemvidutide Clinical Data at Upcoming American Diabetes Association's Scientific SessionsGlobeNewsWire • 06/18/24
Investors who lost money on Altimmune, Inc. (ALT) should contact Levi & Korsinsky about pending Class Action - ALTAccesswire • 06/18/24
Altimmune, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 5, 2024 to Discuss Your Rights – ALTAccesswire • 06/18/24
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 5, 2024 in Altimmune, Inc. Lawsuit - ALTPRNewsWire • 06/17/24
ALT ANNOUNCEMENT: If You Have Suffered Losses in Altimmune, Inc. (NASDAQ: ALT), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewsWire • 06/16/24
UPCOMING ALT DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action LawsuitAccesswire • 06/16/24
ALT SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action Lawsuit!Accesswire • 06/13/24
Edelson Lechtzin LLP Reminds Investors of Looming Deadline in the Altimmune, Inc. (NASDAQ: ALT) Securities Fraud Class ActionAccesswire • 06/13/24
ROSEN, A LONGSTANDING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALTGlobeNewsWire • 06/12/24
Shareholders that lost money on Altimmune, Inc. (ALT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn MoreAccesswire • 06/12/24
Investors Who Lost Money on Altimmune, Inc.(ALT) Should Contact Levi & Korsinsky About Pending Class Action - ALTAccesswire • 06/12/24
Levi & Korsinsky Reminds Altimmune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 5, 2024 – ALTAccesswire • 06/12/24
Shareholders that lost money on Altimmune, Inc. (ALT) should contact Levi & Korsinsky about pending Class Action - ALTAccesswire • 06/10/24
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming Deadlines – ALTAccesswire • 06/09/24
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALTGlobeNewsWire • 06/07/24
Altimmune, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before July 5, 2024 to Discuss Your Rights – ALTGlobeNewsWire • 06/06/24
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALTPRNewsWire • 06/05/24
Altimmune Presents Data at EASL International Liver Congress™ 2024 Supporting the Disease Modifying Potential and Differentiated Therapeutic Profile of Pemvidutide in Metabolic Dysfunction-Associated Steatohepatitis (MASH)GlobeNewsWire • 06/05/24
Altimmune, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - ALTPRNewsWire • 06/05/24
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Altimmune, Inc. Investors to Join the Class Action LawsuitAccesswire • 06/04/24